Reaction
Gastroenteritis Adenovirus reporting signals
As of the last recalculation, Gastroenteritis Adenovirus appears in 155 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is THIOTEPA (PRR 419.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Thiotepa | 25 | 419.0 | 420.1 |
| Alemtuzumab | 21 | 168.5 | 168.7 |
| Fludarabine Phosphate | 37 | 165.7 | 165.8 |
| Melphalan Hydrochloride | 22 | 137.2 | 137.3 |
| Melphalan | 18 | 120.1 | 120.2 |
| Busulfan | 10 | 91.2 | 91.2 |
| Teduglutide | 7 | 73.0 | 73.1 |
| Canakinumab | 4 | 50.9 | 51.0 |
| Palivizumab | 4 | 35.9 | 35.9 |